Products | Biopsy Systems | February 02, 2016

Fusion Bx

Fusion Bx

Related Content

new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS
Feature | Radiation Oncology | By Melinda Taschetta-Millane
Advancements in Diagnostic Radiology Video Series with Robert L. Bard, MD, PC, DABR, FASLMS

In a new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS ...

Time April 10, 2024
arrow
With the addition of MIM Software, GE HealthCare aims to provide clinicians and healthcare systems with increasingly integrated and automated solutions
News | Radiology Business
GE HealthCare Closes MIM Software Acquisition

April 2, 2024 — Less than three months after signing an agreement to acquire MIM Software Inc., GE HealthCare ...

Time April 02, 2024
arrow
For the first time in a commercial setting, physicians are able to see the extent of disease and provide more personalized and precise treatments for prostate cancer patients using AI
News | Artificial Intelligence
Avenda Health Announces First Commercial Use of Unfold AI on Prostate Cancer Patients in the US

March 21, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care ...

Time March 21, 2024
arrow
Videos | Radiation Oncology
VIDEO: Advancements and New Technology in Diagnostic Radiology to Help in the Fight Against Cancer

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
DeepHealth is a global leader in providing AI-powered radiology and health informatics for real-world clinical settings and large-scale screening programs
News | Artificial Intelligence
DeepHealth to Present Latest Results from AI-powered Screening and Diagnostic Programs at the European Congress of Radiology 2024

February 26, 2024 — DeepHealth, Inc., one of the leading providers in healthcare radiology informatics, has today ...

Time February 26, 2024
arrow
First reported clinical results from independent clinical experience by University of Augsburg demonstrated encouraging preliminary data for 177Lu-rhPSMA-10.1
News | Radiopharmaceuticals and Tracers
Blue Earth Therapeutics Announces Publication of Results from Independent Clinical Experience with 177Lu-rhPSMA-10.1 in Treatment of Metastatic Castrate Resistant Prostate Cancer

February 21, 2024 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...

Time February 21, 2024
arrow
Proscia, a software company accelerating the transformation to digital pathology, has announced its receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Concentriq AP-Dx for the purpose of primary diagnosis.
News | FDA
Proscia Receives FDA Clearance for Digital Pathology Software Solution

February 12, 2024 — Proscia, a leading provider of digital and computational pathology solutions, has received 510(k) ...

Time February 12, 2024
arrow
Expanding computer tools find tiny details to help predict how quickly cancer may spread, guiding treatment decisions
News | Artificial Intelligence
Artificial Intelligence Supports Fast, Accurate Cancer Detection

January 25, 2024 — Digital pathology has both sped up and increased the accuracy of cancer diagnosis over the past 10 ...

Time January 25, 2024
arrow
Quibim announced it has added an industry-leading cancer detection capability to its prostate tool based on artificial intelligence (AI).
News | Artificial Intelligence
Quibim Adds Cancer Detection Capability to Prostate AI Product

January 23, 2024 — Quibim announced it has added an industry-leading cancer detection capability to its prostate tool ...

Time January 22, 2024
arrow
The growing emphasis on personalized treatment plans based on a patient’s unique genetic profile and tumor characteristics aims to optimize treatment outcomes while minimizing side effects, and this technology is being used in pediatric oncology. Getty Images
Feature | Radiation Oncology | By Melinda Taschetta-Millane
Special Report: Radiation Oncology Takeaways from RSNA23

Over the past several years, technological advancements have driven the development of more precise and targeted ...

Time January 16, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now